Illumina, Inc. (ILMN) Acquires BlueGnome Limited, Leading Provider of Cytogenetics and In Vitro Fertilization Screening Solutions  
9/19/2012 8:38:01 AM

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Cambridge, U.K.-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of Illumina, is a leading provider of solutions for the screening of genetic abnormalities associated with developmental delay, cancer, and infertility.